Rolontis

FDA shoots down Spectrum's neutropenia drug, citing manufacturing issues
Endpoints
Fri, 08/6/21 - 11:06 am
Spectrum Pharmaceuticals
FDA
neutropenia
cancer
Rolontis
Spectrum's Rolontis hits another setback as FDA faces COVID-19 plant inspection backlog
Fierce Pharma
Tue, 10/27/20 - 11:55 am
Spectrum Pharmaceuticals
neutropenia
Rolontis
drug launches
pandemic
COVID-19
Spectrum's Rolontis Meets Primary Endpoint in Ph III Study for Neutropenia
CP Wire
Fri, 06/29/18 - 10:07 am
Spectrum Pharmaceuticals
Rolontis
neutropenia